Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

February 2013

P&T Committee Update 


At a December 3, 2012 meeting, the Harvard Pilgrim’s Pharmacy & Therapeutics Committee reviewed several drugs and decided the following:

P&T Committee Review and Decisions

Name Indication Decision
Xarelto
(rivaroxaban)
Xarelto is an Xa inhibitor anticoagulant used for:
•    the prevention of stroke in patients with nonvalvular atrial fibrillation.
•    to reduce deep vein thrombosis in patients who have had a knee or hip replacement
•    to treat and prevent the recurrence of deep vein thrombosis and pulmonary embolism
Xarelto is in the same therapeutic category as warfarin (Coumadin).
Continued coverage at Tier 3
(Tier 4 for 4-Tier formulary)
Pradaxa
(dabigatran)
Pradaxa is a direct thrombin inhibitor anticoagulant used to reduce the risk of stroke and systemic blood clots in patients with nonvalvular atrial fibrillation. Pradaxa is in the same therapeutic category as warfarin (Coumadin). Continued coverage at Tier 3
(Tier 4 for 4-Tier formulary)
Brilinta
(ticagrelor)
Brilinta is used in conjunction with aspirin for secondary prevention of thrombotic events in patients with acute coronary syndrome. Brilinta is in the same therapeutic category as clopidogrel (Plavix). Continued coverage at Tier 3
(Tier 4 for 4-Tier formulary)
Relistor
(methylnaltrexone)
Relistor is used to treat opioid-induced constipation in patients with advanced illness who are receiving palliative care. It is given by subcutaneous injection every other day, as needed. Moved to Tier 2
(Tier 3 for 4-Tier formulary)

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

Update: New Dartmouth-Hitchcock Employee Medical Plan

Growing the Medicare Advantage Network

CLINICIAN CORNER

Reminder: Timing of preventive care visits

P&T Committee Update

Measures aimed at boosting SNF/PCP care coordination

Talking to children about tragedy in the primary care setting

OFFICE ASSISTANT

Reminder: CPT code for administering immunizations

Reminder: Member ID prefixes may not indicate particular products

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network and Product Development

Joann Peck,
Manager, Network Planning and Administration

Annmarie Dadoly,
Editor

Kristin Edmonston,
Production Coordinator